# Federal Register #DEA-1730P

DEA Notice on Proposed Controlled-Substance Quotas and Chemical Needs

**Buyer:** Justice Department / Drug Enforcement Administration
**Posted:** November 10, 2026
**Respond By:** December 11, 2026
**Identifier:** DEA-1730P

The Drug Enforcement Administration is seeking public input on proposed controlled-substance production quotas and chemical needs assessments.
- **Government buyer:** U.S. Department of Justice, Drug Enforcement Administration (DEA); no specific sub-agency office is identified.
- **Notice purpose:** Request for public comments on proposed aggregate production quotas for Schedule I and II controlled substances and annual needs assessments for ephedrine, pseudoephedrine, and phenylpropanolamine.
- **Basis for proposed amounts:** U.S. medical, scientific, research, and industrial needs; lawful exports; and reserve stocks.
- **Procurement status:** This is a regulatory notice, not a solicitation or government purchase. No OEMs, vendors, products for purchase, quantities, or part numbers are identified.

### Description

The Drug Enforcement Administration proposes to establish 2027 aggregate production quotas for Schedule I and II controlled substances and assess annual needs for the List I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine. The proposed quantities are intended to meet estimated U.S. medical, scientific, research, and industrial needs, lawful export requirements, and reserve-stock needs. The notice requests comments, which must be submitted or postmarked by December 10, 2026.

[View original listing](https://www.federalregister.gov/documents/2026/11/10/2026-22843/proposed-aggregate-production-quotas-for-schedule-i-and-ii-controlled-substances-and-assessment-of)